Abstract
Longterm goitrogen administration to rodents is well known to result in multiple proliferative lesions of the thyroid. The regression of these lesions on withdrawal of goitrogen has led to their neoplastic nature being questioned, and they have been regarded as 'nodules' rather than as true tumours. We have induced multiple thyroid lesions by the combined use of high dose radiation as a mutagen, together with goitrogen administration to induce prolonged TSH growth stimulation. G6PD histochemistry was used in heterozygous G6PD deficient female mice to show that all the thyroid lesions induced by this regime were monophenotypic, and therefore monoclonal in origin. The great majority of induced tumours were adenomas, a minority were carcinomas. The number of carcinomas observed was significantly lower in a group of animals from which goitrogen was withdrawn for 4 weeks prior to killing, when compared to animals killed while on goitrogen treatment. Both adenomas and carcinomas, including areas of intravascular tumour, showed morphological features of regression on withdrawal of the goitrogen. There are three key cellular changes which must occur in spontaneous thyroid carcinogenesis--escape from a growth limiting mechanism, acquisition of TSH independent growth and acquisition of invasiveness. In the natural selection of mutations or epimutations during carcinogenesis, prolonged high levels of TSH are likely to remove any selective advantage from mutations that lead to TSH independent growth. Tumours induced by a regime including prolonged goitrogen treatment may therefore develop following two rather than three key stages. They will occur with an increased frequency relative to lesions observed in spontaneous carcinogenesis, but will retain TSH dependency. We speculate that several mechanisms may lead to loss of the growth limiting mechanism, including translocation of an oncogene to the region of a TSH induced promoter. Other carcinogenic regimes may also increase the yield of tumours by creating conditions which reduce the number of essential steps required for carcinogenesis, and may involve translocation to a carcinogen inducible promoter.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dalla-Favera R., Bregni M., Erikson J., Patterson D., Gallo R. C., Croce C. M. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A. 1982 Dec;79(24):7824–7827. doi: 10.1073/pnas.79.24.7824. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Finlay C. A., Hinds P. W., Levine A. J. The p53 proto-oncogene can act as a suppressor of transformation. Cell. 1989 Jun 30;57(7):1083–1093. doi: 10.1016/0092-8674(89)90045-7. [DOI] [PubMed] [Google Scholar]
- Heisterkamp N., Stephenson J. R., Groffen J., Hansen P. F., de Klein A., Bartram C. R., Grosveld G. Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature. 1983 Nov 17;306(5940):239–242. doi: 10.1038/306239a0. [DOI] [PubMed] [Google Scholar]
- Jemec B. Studies of the tumorigenic effect of two goitrogens. Cancer. 1977 Nov;40(5):2188–2202. doi: 10.1002/1097-0142(197711)40:5<2188::aid-cncr2820400529>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
- MORRIS H. P., GREEN C. D. The role of thiouracil in the induction, growth, and transplantability of mouse thyroid tumors. Science. 1951 Jul 13;114(2950):44–46. doi: 10.1126/science.114.2950.44. [DOI] [PubMed] [Google Scholar]
- Matovinovic J., Nishiyama R. H., Poissant G. Transplantable thyroid tumors in the rat: development of normal-appearing thyroid follicles in the differentiated tumors, and development of differentiated tumors from iodine-deficient, thyroxine-involuted goiters. Cancer Res. 1970 Feb;30(2):504–514. [PubMed] [Google Scholar]
- Nowell P. C. Tumors as clonal proliferation. Virchows Arch B Cell Pathol. 1978 Nov 17;29(1-2):145–150. doi: 10.1007/BF02899348. [DOI] [PubMed] [Google Scholar]
- PURVES H. D., GRIESBACH W. E., KENNEDY T. H. Studies in experimental goitre: malignant change in a transplantable rat thyroid tumour. Br J Cancer. 1951 Sep;5(3):301–310. doi: 10.1038/bjc.1951.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pretsch W., Charles D. J., Merkle S. X-linked glucose-6-phosphate dehydrogenase deficiency in Mus musculus. Biochem Genet. 1988 Feb;26(1-2):89–103. doi: 10.1007/BF00555491. [DOI] [PubMed] [Google Scholar]
- Thomas G. A., Williams D., Williams E. D. The clonal origin of thyroid nodules and adenomas. Am J Pathol. 1989 Jan;134(1):141–147. [PMC free article] [PubMed] [Google Scholar]
- Thomas G. A., Williams D., Williams E. D. The demonstration of tissue clonality by X-linked enzyme histochemistry. J Pathol. 1988 Jun;155(2):101–108. doi: 10.1002/path.1711550205. [DOI] [PubMed] [Google Scholar]
- Todd G. C. Induction and reversibility of thyroid proliferative changes in rats given an antithyroid compound. Vet Pathol. 1986 Mar;23(2):110–117. doi: 10.1177/030098588602300202. [DOI] [PubMed] [Google Scholar]
- WOLLMAN S. H. PRODUCTION AND PROPERTIES OF TRANSPLANTABLE TUMORS OF THE THYROID GLAND IN THE FISCHER RAT. Recent Prog Horm Res. 1963;19:579–618. [PubMed] [Google Scholar]
- Wynford-Thomas D., Stringer B. M., Williams E. D. Dissociation of growth and function in the rat thyroid during prolonged goitrogen administration. Acta Endocrinol (Copenh) 1982 Oct;101(2):210–216. doi: 10.1530/acta.0.1010210. [DOI] [PubMed] [Google Scholar]